Multiple phosphorylation sites are important for RUNX1 activity in early hematopoiesis and T-cell differentiation

European Journal of Immunology

Volumn 42, Issue 4, 2012, Pages 1044-1050

  Yoshimi, Mayumi ^a   Goyama, Susumu ^a,e   Kawazu, Masahito ^a   Nakagawa, Masahiro ^a   Ichikawa, Motoshi ^a   Imai, Yoichi ^a   Kumano, Keiki ^b   Asai, Takashi ^a   Mulloy, James C ^e   Kraft, Andrew S ^c   Takahashi, Tsuyoshi ^a,b   Shirafuji, Naoki ^d   Kurokawa, Mineo ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d TEIKYO UNIVERSITY   (Japan)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Hematopoiesis; Phosphorylation; Posttranslational modification; RUNX1; T cell differentiation

Indexed keywords

ALANINE; ASPARTIC ACID; CD44V ANTIGEN; CD45 ANTIGEN; GLUTAMIC ACID; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR RUNX1;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL MATURATION; CONTROLLED STUDY; GENE MUTATION; HEMATOPOIESIS; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; RETROVIRUS; T LYMPHOCYTE DIFFERENTIATION;

AMINO ACID SUBSTITUTION; ANIMALS; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; HEMATOPOIESIS; MICE; MICE, KNOCKOUT; MUTATION, MISSENSE; PEPTIDE MAPPING; PHOSPHORYLATION; T-LYMPHOCYTES;

EID: 84860248542     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040746     Document Type: Article

References (23)

1. Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y. and Ohki, M., t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 1991. 88: 10431-10434.
2. Imai, Y., Kurokawa, M., Izutsu, K., Hangaishi, A., Takeuchi, K., Maki, K., Ogawa, S. et al., Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis. Blood 2000. 96: 3154-3160.
3. Kurokawa, M., AML1/Runx1 as a versatile regulator of hematopoiesis: regulation of its function and a role in adult hematopoiesis. Int. J. Hematol. 2006. 84: 136-142.
4. Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G. and Downing, J. R., AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996. 84: 321-330.
5. Ichikawa, M., Asai, T., Saito, T., Yamamoto, G., Seo, S., Yamazaki, I., Yamagata, T. et al., AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 2004. 10: 299-304.
6. Taniuchi, I., Osato, M., Egawa, T., Sunshine, M. J., Bae, S. C., Komori, T., Ito, Y. and Littman, D. R., Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 2002. 111: 621-633.
7. Goyama, S., Yamaguchi, Y., Imai, Y., Kawazu, M., Nakagawa, M., Asai, T., Kumano, K. et al., The transcriptionally active form of AML1 is required for hematopoietic rescue of the AML1-deficient embryonic para-aortic splanchnopleural (P-Sp) region. Blood 2004. 104: 3558-3564.
8. Kawazu, M., Asai, T., Ichikawa, M., Yamamoto, G., Saito, T., Goyama, S., Mitani, K. et al., Functional domains of Runx1 are differentially required for CD4 repression, TCRbeta expression, and CD4/8 double-negative to CD4/8 double-positive transition in thymocyte development. J. Immunol. 2005. 174: 3526-3533.
9. Tanaka, T., Kurokawa, M., Ueki, K., Tanaka, K., Imai, Y., Mitani, K., Okazaki, K. et al., The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability. Mol. Cell. Biol. 1996. 16: 3967-3979.
10. Imai, Y., Kurokawa, M., Yamaguchi, Y., Izutsu, K., Nitta, E., Mitani, K., Satake, M. et al., The corepressor mSin3A regulates phosphorylation-induced activation, intranuclear location, and stability of AML1. Mol. Cell. Biol. 2004. 24: 1033-1043.
11. Zhang, Y., Biggs, J. R. and Kraft, A. S., Phorbol ester treatment of K562 cells regulates the transcriptional activity of AML1c through phosphorylation. J. Biol. Chem. 2004. 279: 53116-53125.
12. Aikawa, Y., Nguyen, L. A., Isono, K., Takakura, N., Tagata, Y., Schmitz, M. L., Koseki, H. and Kitabayashi, I., Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation. EMBO J. 2006. 25: 3955-3965.
13. Biggs, J. R., Peterson, L. F., Zhang, Y., Kraft, A. S. and Zhang, D. E., AML1/RUNX1 phosphorylation by cyclin-dependent kinases regulates the degradation of AML1/RUNX1 by the anaphase-promoting complex. Mol. Cell. Biol. 2006. 26: 7420-7429.
14. Wang, S., Zhang, Y., Soosairajah, J. and Kraft, A. S., Regulation of RUNX1/AML1 during the G2/M transition. Leuk Res 2007. 31: 839-851.
15. Zhang, L., Fried, F. B., Guo, H. and Friedman, A. D., Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation. Blood 2008. 111: 1193-1200.
16. Tachibana, M., Tezuka, C., Muroi, S., Nishimoto, S., Katsumoto, T., Nakajima, A., Kitabayashi, I. and Taniuchi, I., Phosphorylation of Runx1 at Ser249, Ser266, and Ser276 is dispensable for bone marrow hematopoiesis and thymocyte differentiation. Biochem. Biophys. Res. Commun. 2008. 368: 536-542.
17. Schmitt, T. M. and Zuniga-Pflucker, J. C., Induction of T-cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 2002. 17: 749-756.
18. Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E. et al., Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 1998. 273: 18623-18632.
19. Fischer, A. M., Katayama, C. D., Pages, G., Pouyssegur, J. and Hedrick, S. M., The role of erk1 and erk2 in multiple stages of T-cell development. Immunity 2005. 23: 431-443.
20. Yamaguchi, Y., Kurokawa, M., Imai, Y., Izutsu, K., Asai, T., Ichikawa, M., Yamamoto, G. et al., AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues. J. Biol. Chem. 2004. 279: 15630-15638.
21. Zhao, X., Jankovic, V., Gural, A., Huang, G., Pardanani, A., Menendez, S., Zhang, J. et al., Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. Genes. Dev. 2008. 22: 640-653.
22. Takahama, Y., Ohishi, K., Tokoro, Y., Sugawara, T., Yoshimura, Y., Okabe, M., Kinoshita, T. and Takeda, J., Functional competence of T cells in the absence of glycosylphosphatidylinositol-anchored proteins caused by T cell-specific disruption of the Pig-a gene. Eur. J. Immunol. 1998. 28: 2159-2166.
23. Kitamura, T., Koshino, Y., Shibata, F., Oki, T., Nakajima, H., Nosaka, T. and Kumagai, H., Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp. Hematol. 2003. 31: 1007-1014.